The head of the company that hiked EpiPen prices will now have to answer to lawmakers.
Mylan CEO, Heather Bresch, will testify at a House Committee meeting next Wednesday, Sept. 21.
Over the last few years the prices for the life-saving medication have increased by 500 percent. Lawmakers say they'll question Bresch about that huge increase and look at way's to speed up approving generics for the medicine.
Download the ABC2 News app for the iPhone, Kindle and Android.
